- Home
- LSF vs INMB Comparison
LSF vs INMB Comparison
Compare LSF & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LSF | INMB |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.0M | 39.6M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | LSF | INMB |
|---|---|---|
| Price | $4.44 | $1.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $6.00 | $5.40 |
| AVG Volume (30 Days) | 72.0K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.28 | 11.85 |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $49,889,286.00 | $50,000.00 |
| Revenue This Year | $90.82 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $42.73 | ★ N/A |
| Revenue Growth | 15.23 | ★ 257.14 |
| 52 Week Low | $1.96 | $1.09 |
| 52 Week High | $7.80 | $3.24 |
Technical Indicators
Market Signals| Indicator | LSF | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 51.10 | 62.45 |
| Support Level | $3.00 | $1.77 |
| Resistance Level | $5.11 | $2.30 |
| Average True Range (ATR) | 0.35 | 0.18 |
| MACD | -0.09 | 0.03 |
| Stochastic Oscillator | 17.28 | 66.89 |
Price Performance
Historical ComparisonAbout LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the development and marketing of food and beverage products focused on health and wellness. The company's product portfolio includes coffee creamers, coffee, tea, hot chocolate, hydration and beverage enhancement products, and snacks, made using natural and functional ingredients.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.